Cambrium
GermanyEntry
2020
Hold
6yr
Status
Active
Who owns Cambrium?
Cambrium is a German Biotech company, currently owned by Redstone since 2025 and Merantix Capital.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
Merantix CapitalMerantix Capital Fund I · 2020 · VC
2 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Merantix CapitalActive
2020 · present(6yr) · Merantix Capital Fund I · 2020 · VC
RedstoneActive
2025 · present(1yr) · Redstone Ventures · 2014 · Evergreen
More from Merantix Capital Fund I
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Cambrium?
Cambrium is currently owned by Redstone and Merantix Capital, through Merantix Capital Fund I, since 2025.
When did Redstone and 1 other acquire Cambrium?
Redstone and 1 other acquired Cambrium in 2025.
Who has owned Cambrium over time?
Cambrium has been through 2 private-equity ownership periods: Merantix Capital · via Merantix Capital Fund I · since 2020; Redstone · via Redstone Ventures · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue